406 filings
Page 18 of 21
6-K
KMDA
Kamada Ltd
18 Aug 14
Current report (foreign)
12:00am
6-K
KMDA
Kamada Ltd
14 Aug 14
Kamada Reports Second Quarter Financial Results
12:00am
SC 13G/A
FMR LLC
10 Jul 14
Kamada LTD
12:00am
6-K
KMDA
Kamada Ltd
23 Jun 14
Current report (foreign)
12:00am
6-K
KMDA
Kamada Ltd
5 Jun 14
Current report (foreign)
12:00am
SC 13G
Migdal Insurance & Financial Holdings Ltd.
19 May 14
Kamada LTD
12:00am
6-K
KMDA
Kamada Ltd
16 May 14
Kamada Announces Preliminary Results from Phase II/III Pivotal Trial in Europe
12:00am
6-K
KMDA
Kamada Ltd
15 May 14
Kamada to Announce Results from Phase 2/3 Clinical Trial of Inhaled AAT to
12:00am
6-K
KMDA
Kamada Ltd
15 May 14
Current report (foreign)
12:00am
6-K
KMDA
Kamada Ltd
15 May 14
Current report (foreign)
12:00am
6-K
KMDA
Kamada Ltd
12 May 14
Current report (foreign)
12:00am
6-K
KMDA
Kamada Ltd
8 May 14
Kamada Reports First Quarter Financial Results
12:00am
6-K
KMDA
Kamada Ltd
24 Apr 14
Lowers time from preparation to finish for patients with Alpha-1 Antitrypsin
12:00am
6-K
KMDA
Kamada Ltd
3 Apr 14
Kamada Announces U.S. Proof-of-Concept Study with Glassia® for Graft-Versus-Host Disease
12:00am
20-F
2013 FY
KMDA
Kamada Ltd
26 Mar 14
Annual report (foreign)
12:00am
6-K
KMDA
Kamada Ltd
26 Mar 14
Israeli Securities Law Regulations (Periodic and Immediate Reports) 9d
12:00am
6-K
KMDA
Kamada Ltd
24 Mar 14
Kamada Announces Initiation of a Phase 2 U.S. Clinical Trial of Inhaled AAT to
12:00am
6-K
KMDA
Kamada Ltd
21 Mar 14
Kamada to Report Top-Line Data from Phase 2/3 Clinical Trial of Inhaled AAT to
12:00am
6-K
KMDA
Kamada Ltd
5 Mar 14
Current report (foreign)
12:00am
6-K
KMDA
Kamada Ltd
4 Mar 14
Kamada Completes Enrollment in U.S. Pivotal Clinical Trial with KamRAB as a
12:00am